Matthew T. Seibt
Keine laufenden Positionen mehr
Karriereverlauf von Matthew T. Seibt
Ehemalige bekannte Positionen von Matthew T. Seibt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACER THERAPEUTICS INC. | Corporate Officer/Principal | 01.04.2018 | 01.03.2023 |
Ausbildung von Matthew T. Seibt
| The University of Texas at Austin | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Börse
- Insiders
- Matthew T. Seibt
- Erfahrung
